Jul 9, 2025, 09:14 AM by

SPT Labtech today announced a strategic collaboration with Semarion. The partnership will integrate SPT Labtech’s firefly® liquid handling platform with Semarion’s SemaCyte® microcarrier technology to develop a flexible, scalable, and automated workflow that simplifies and accelerates key stages of adherent cell assay development.

Jul 9, 2025, 01:00 AM by User Not Found

Bio-IT World | Consumer genomics pioneer 23andMe will be returning to its co-founder and former CEO as Anne Wojcicki’s TTAM Research Institute outbids Regeneron to buy 23andMe out of bankruptcy—as long as no more state attorneys general object. The current iteration of the sale is expected to close on July 8.

Jul 8, 2025, 01:00 AM by User Not Found

Bio-IT World | Pangaea Data has entered into a collaboration agreement with Alexion to develop an Artificial Intelligence Clinical Decision Support System; Dell Technologies will develop NERSC-10, the next flagship supercomputer at the National Energy Research Scientific Computing Center; and more.

Jul 7, 2025, 08:29 AM by

Jul 7, 2025, 08:29 AM by

CD Bioparticles announces quality Purified Exosomes to support research in drug delivery.

Jul 7, 2025, 08:29 AM by

Jul 3, 2025, 08:19 AM by

PHARMASEAL, provider of the Engility® Trial Management Platform consisting of a Clinical Trial Management System (CTMS) CTMS and Electronic Trial Master File (eTMF), has announced a Technology Integration Partnership with Viedoc, a global leader in Electronic Data Capture (EDC) and eClinical technologies. This collaboration integrates PHARMASEAL’s advanced CTMS platform with Viedoc’s cutting-edge EDC capabilities, including its flagship product Viedoc Clinic, to deliver a more integrated solution for life science companies managing clinical trials worldwide.

Jul 3, 2025, 08:19 AM by

The research will focus on developing faster and more accurate methods for predicting drug metabolism

Jul 3, 2025, 01:00 AM by User Not Found

Bio-IT World | In a commentary published last week in Cell, researchers from the Arc Institute introduced the “Virtual Cell Challenge,” a public competition with a grand prize worth $100,000 for the machine learning model that best predicts how cells will respond to genetic perturbations.

Jul 2, 2025, 08:36 AM by

Jul 2, 2025, 08:36 AM by

Femasys has received regulatory approvals in Australia and New Zealand for its innovative infertility solutions—FemaSeed®, a first-line, intratubal insemination treatment, and FemVue®, a diagnostic tool for assessing fallopian tube patency. These approvals mark a strategic expansion of the company’s global footprint and further validate its mission to offer more accessible, less invasive, and cost-effective fertility care. With FemaSeed shown to more than double pregnancy rates over traditional IUI in clinical trials, and FemVue enabling real-time fertility diagnostics in-office, this milestone offers new hope to patients facing infertility and strengthens Femasys’ commercial potential in international markets.

Jul 2, 2025, 08:36 AM by

Jul 2, 2025, 08:35 AM by

Gene by Gene Supports Landmark Pharmacogenomics Trial to Personalize Prescribing in NHS Scotland

Jul 2, 2025, 01:00 AM by User Not Found

Bio-IT World | Consumer genomics pioneer 23andMe will be returning to its co-founder and former CEO as Anne Wojcicki’s TTAM Research Institute outbids Regeneron to buy 23andMe out of bankruptcy—as long as no more state attorneys general object. The current iteration of the sale is expected to close on July 8.

Jul 1, 2025, 08:19 AM by

PharmaForceIQ has announced a period of significant growth as it goes beyond omnichannel to optichannel campaign solutions. The company is the fastest growing independent provider of precision customer engagement technologies for the Life Science industry, and it has experienced a multifold increase in average contract value in the past year. In one client, the company expanded from a pilot campaign for one specialty brand to their entire specialty pharmaceutical portfolio in only 7 months. PharmaForceIQ also has a 100% client renewal rate – demonstrating that its data-driven strategies deliver unmatched efficiency and tangible results

Jul 1, 2025, 08:19 AM by

Oxford-based Ochre Bio, a biotechnology company developing RNA therapeutics for chronic liver disease, has appointed Dr Quin Wills as CEO.

Jul 1, 2025, 08:19 AM by

Jul 1, 2025, 08:19 AM by

Takara Bio Europe is pleased to announce it has entered into a distribution agreement with MACHEREY-NAGEL to expand access to high-quality bioanalysis products.

Jul 1, 2025, 01:00 AM by User Not Found

Bio-IT World | In Stanford University's engineering labs, Tom Soh has been wrestling with a paradox that has plagued medicine for decades. While modern jet engines generate terabytes of data every hour to prevent catastrophic failures, the human body gets monitored only during annual checkups or after something has already gone wrong.

Jun 30, 2025, 08:12 AM by

Rewriting the Timeline of Detection: Linus Health's Digital Platform Uncovers the Earliest Signs of Cognitive Decline